Physician profile
Stephanie Renee Morrison
NPI 1457081630
$5,499.15
in general payments reported to CMS, 2019-2025
13 companies · $3,520 in 2025
The $3,520 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $296 · 2023: $737 · 2024: $946 · 2025: $3,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,075 · Food and Beverage: $2,025 · Travel and Lodging: $863 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,075.00 |
| Food and Beverage | $2,025.16 |
| Travel and Lodging | $862.92 |
| Education | $239.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $2,921.48 | 2025 | Zepbound |
| Jazz Pharmaceuticals INC. | $849.75 | 2022-2025 | |
| Harmony Biosciences LLC | $505.09 | 2023-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $413.23 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $356.36 | 2023-2024 | Sunosi |
| Idorsia Pharmaceuticals US INC | $127.16 | 2023 | Quviviq |
| Medtronic, INC. | $89.87 | 2025 | Mycarelink |
| Inspire Medical Systems, INC. | $63.45 | 2024 | Inspire |
| Resmed Corp | $63.41 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $57.06 | 2025 | Verquvo |
| Pfizer INC. | $23.95 | 2024 | |
| Glaxosmithkline, LLC. | $14.87 | 2025 | Arexvy, Shingrix |
| Amgen INC. | $13.47 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.